Real World
Use Cases

Powered by SEQSTER

From early discovery to post-market surveillance, our platform enables faster decisions, smarter studies, and deeper insight into the patient journey.

01

Accelerated Clinical Trial Recruitment and Screening

Enable patients to securely connect their electronic health records from multiple providers in minutes.

02

Open Patient Registries for Continuous Study Pipelines

Open, patient-centric registries that collect real-world clinical data directly from source systems, with patient consent.

03

Post-Market Real-World Evidence and Surveillance

Continuous access to clinical data after product launch, without requiring site contracts or repeated patient outreach.

04

Rare Disease and Underserved Population Research

Empower patients to self-enroll and share verified clinical records regardless of location or health system.

05

Patient Support Programs and Long-Term Outcome Tracking

Patient support and monitoring that continuously updates medical histories and outcomes over time.

See SEQSTER in Action.
Contact Us Today.

Accelerated Clinical Trial Recruitment and Screening

Identifying the right patients is time-consuming, and medical records are incomplete or unavailable. SEQSTER enables patients to securely connect their electronic health records from multiple providers in minutes. Sponsors and their research teams gain instant access to structured, longitudinal medical histories that can be queried against inclusion and exclusion criteria in real time.

Sponsors move faster with confidence, enrolling the right patients earlier while reducing operational burden across sites and CROs.

Early identification of eligible
patients before site referral
Rapid screening of thousands
of potential participants
Reduced dependency on
manual chart review
Enrollment timelines shortened
from years to months

Open Patient Registries for Continuous Study Pipelines

One-off studies limit learning and slow future programs. SEQSTER supports open, patient-centric registries that continuously collect real-world clinical data directly from source systems, with patient consent.

Sponsors build living data assets that fuel present and future trials while delivering meaningful value back to patients.

Reuse of high-quality longitudinal
data across a portfolio
Ongoing identification of
patients across multiple studies
Seamless referral of patients between
studies as eligibility changes
Deeper understanding of disease
progression and care patterns

Post-Market Real World Evidence and Surveillance

Long-term safety and outcome tracking is resource-intensive and incomplete. SEQSTER provides continuous access to real-world clinical data after product launch, without requiring site contracts or repeated patient outreach.

Sponsors gain a clear, ongoing view of how therapies perform in the real world, supporting both regulatory obligations and scientific insight.

Longitudinal monitoring over
multiple years
Real-time capture of clinical
visits, outcomes, and events
Support for safety programs
and regulatory reporting
Reduced reliance on
retrospective data retrieval

Rare Disease and Underserved Population Research

Patients are geographically dispersed and data is difficult to aggregate. SEQSTER empowers patients to self-enroll and share verified clinical records regardless of location or health system.

Sponsors uncover insights that would otherwise remain hidden, accelerating research in areas with the greatest unmet need.

Reuse of high-quality longitudinal
data across a portfolio
Ongoing identification of
patients across multiple studies
Seamless referral of patients between
studies as eligibility changes
Deeper understanding of disease
progression and care patterns

Patient Support Programs and Long-Term Outcome Tracking

Maintaining sustained engagement and visibility outside traditional clinical trial settings is challenging, such as in Risk Evaluation and Mitigation Strategy (REMS) registries. SEQSTER supports patient support and monitoring programs by continuously updating medical histories and outcomes over time.

Programs become more scalable, more patient-centric, and more informative across the full lifecycle of care.

Reduced administrative
burden for support teams
Longitudinal tracking of patient health and therapy impact A single, unified health record
for both patients and sponsors
Improved patient experience
through transparency and access